75eP Mutational spectrum of KRAS, TP53, BRAF, ERBB2, and POLE in GI malignancies across diverse populations
Nikhil GhadyalpatilDepartment of Medical Oncology, Apollo Cancer Institute - Hyderabad, Hyderabad, IndiaUmut DişelMedical Oncology Department, Acibadem Adana Hastanesi, Adana, TürkiyeO. ZilolaMedical Oncology, Ilboza Med Llc, Tashkant, UzbekistanVrushali KhobragadeResearch, 1Cell.Ai, Pune, IndiaAtul BhardeCancer Genomics, 1Cell.Ai, Pimpri-Chinchwad, IndiaSevgin DeğirmencioğluMedical Oncology Department, Pamukkale University - Faculty of Medicine, Denizli, TürkiyeAhmet DiricanMedical Oncology Department, MCBU-Manisa Celal Bayar University - Faculty of Medicine, Manisa, TürkiyeD. FarrukhTashkent Medical Park Llc, HOD Oncology Department, Tashkant, UzbekistanAhmed AbdelazizValue & Access, Novartis Pharma, Cairo, EgyptSaroj SapkotaDepartment of Clinical Oncology, KCC - Kathmandu Cancer Center, Bhaktapur, NepalKananathan RatnaveluMedical Oncology, Consultant Medical Oncologist, Columbia Asia, MalaysiaY. UrunMedical Oncology Department, Ankara University Medical School - Cebeci Hastaneleri Tibbi Onkoloji, Ankara, TürkiyeLoai Z SbeihMedical Oncology, Amman, JordanHrishita KothavadeMolecular Pathology Dept., 1Cell.Ai, Pune, IndiaJayant KhandareGenomics, 1Cell.Ai, Pune, IndiaKumar PrabhashMedical Oncology Department, Tata Memorial Hospital, Mumbai, IndiaGowhar ShafiPrecision Oncology Department, 1Cell.Ai, Pune, IndiaVashista ManiarMedical Oncology, MOC Cancer Care & Research Centre, Mumbai, India
ABI
Аннотация
Аннотация отсутствует.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 0
Показатели — AkademScholar · Скоро